PTGS2 and cancer: In addition, overexpression of COX-2 in several different types of solid tumors has been reported and supported by animal studies that confirmed the association of genetic COX-2 overexpression with tumorigenesis and malignant progression.458 Consistently, more and more s clinical trials showed that COX-2 may be an important target in cancer therapies.